Department of Radiation Oncology, Cell and Molecular Pharmacology and Experimental Therapeutics, Medical University of South Carolina, Charleston, South Carolina 29425, USA.
J Thorac Oncol. 2013 May;8(5):543-8. doi: 10.1097/JTO.0b013e318288dc96.
Tobacco use is associated with poor outcomes in cancer patients, but there is little information from oncology providers on their practice patterns or perceptions regarding tobacco use and smoking cessation in these patients.
An online survey of practices, perceptions, and barriers to tobacco assessment and cessation in cancer patients was conducted in members of the International Association for the Study of Lung Cancer (IASLC). Responses of physician-level respondents were analyzed and reported.
Responses from 1507 IASLC members who completed the survey are reported as representing 40.5% of IASLC members. More than 90% of physician respondents believe current smoking affects outcome and that cessation should be a standard part of clinical care. At the initial patient visit, 90% ask patients about tobacco use, 79% ask patients whether they will quit, 81% advise patients to stop tobacco use, but only 40% discuss medication options, 39% actively provide cessation assistance, and fewer yet address tobacco at follow-up. Dominant barriers to physician cessation effort are pessimism regarding their ability to help patients stop using tobacco (58%) and concerns about patient resistance to treatment (67%). Only 33% report themselves to be adequately trained to provide cessation interventions.
Physicians who care for lung cancer patients recognize the importance of tobacco cessation as a necessary part of clinical care, but many still do not provide assistance to their patients as a routine part of cancer care. Increasing tobacco cessation activities will require increased assessment and cessation at diagnosis and during follow-up, increased clinician education, and improved tobacco cessation methods.
烟草使用与癌症患者的不良预后相关,但在肿瘤学医生的实践模式或对这些患者的烟草使用和戒烟观念方面,相关信息较少。
对国际肺癌研究协会(IASLC)成员进行了一项关于癌症患者中烟草评估和戒烟的实践、看法和障碍的在线调查。分析并报告了医师级应答者的回复。
报告了完成调查的 1507 名 IASLC 成员的回复,这些回复代表了 IASLC 成员的 40.5%。超过 90%的医师应答者认为当前吸烟会影响预后,且戒烟应成为临床护理的标准部分。在初次就诊时,90%的医生会询问患者是否吸烟,79%会询问患者是否打算戒烟,81%会建议患者停止吸烟,但仅有 40%会讨论药物选择,39%会积极提供戒烟帮助,而更少的医生会在随访时关注烟草问题。医生戒烟努力的主要障碍是对帮助患者戒烟的能力感到悲观(58%)以及对患者对治疗的抵触感到担忧(67%)。只有 33%的医生报告自己接受过充分的戒烟干预培训。
关注肺癌患者的医生认识到戒烟作为临床护理的必要组成部分的重要性,但许多医生仍未将为患者提供帮助作为癌症护理的常规部分。增加戒烟活动将需要在诊断和随访期间增加评估和戒烟、增加临床医生教育以及改进戒烟方法。